[{"Assets_0_Q1_USD":213209000.0,"CommonStockSharesOutstanding_0_Q1_shares":32967000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-23183000.0,"NetIncomeLoss_1_Q1_USD":-12377000.0,"StockholdersEquity_0_Q1_USD":94424000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]